作者: EXCEL 時(shí)間: 2025-3-22 00:13 作者: 蛙鳴聲 時(shí)間: 2025-3-22 01:57 作者: 草本植物 時(shí)間: 2025-3-22 08:35 作者: 絕種 時(shí)間: 2025-3-22 10:16 作者: irritation 時(shí)間: 2025-3-22 16:35 作者: irritation 時(shí)間: 2025-3-22 19:23 作者: blight 時(shí)間: 2025-3-22 23:13
,Tellerventil mit unterer Führung,ction of neoadjuvant chemoradiation, previously irresectable tumours can nowadays be cured by extensive multivisceral resections. These highly complex operations are associated with significant morbidity and mortality. Due to optimization of chemoradiotherapy, the introduction of IORT, increasing kn作者: Obituary 時(shí)間: 2025-3-23 02:27 作者: 抒情短詩(shī) 時(shí)間: 2025-3-23 07:39
,Arbeitsplan und Bauart der Versuchsk?rper,in the last 5?years, focusing on the impact of rectal cancer treatment on patients’ HRQoL. Of the 477 articles retrieved, 56 met the inclusion criteria. The most frequently reported comparisons were between surgical procedures (21 articles), especially between sphincter-preserving and non-sphincter 作者: 平息 時(shí)間: 2025-3-23 11:32 作者: CRUE 時(shí)間: 2025-3-23 15:38
https://doi.org/10.1007/978-3-662-32623-70 studies on 5?×?5?Gy with delayed surgery (no of patients (.)?=?1343), and six studies on 5?×?5?Gy with consolidation chemotherapy delivered over a long interval prior to surgery in a tight sequence (.?=?244). In total, there were four randomized studies, five phase II studies, and seven retrospect作者: 悠然 時(shí)間: 2025-3-23 19:49 作者: 不可接觸 時(shí)間: 2025-3-23 22:28 作者: deceive 時(shí)間: 2025-3-24 02:35 作者: 憤慨點(diǎn)吧 時(shí)間: 2025-3-24 08:24 作者: Mitigate 時(shí)間: 2025-3-24 11:16 作者: languor 時(shí)間: 2025-3-24 17:52
Florian Otto,Manfred P. LutzUp-to-date overview of the multidisciplinary management of rectal cancer, covering local and metastatic disease.Latest recommendations on diagnosis and multidisciplinary treatment.Written by some of t作者: 啟發(fā) 時(shí)間: 2025-3-24 22:45 作者: 債務(wù) 時(shí)間: 2025-3-25 01:45
https://doi.org/10.1007/978-3-319-08060-4Liver Metastasis; Neoadjuvant Therapy; Primary Theory; Rectal Cancer; Synchronous Metastases; surgical on作者: amygdala 時(shí)間: 2025-3-25 04:11 作者: Tracheotomy 時(shí)間: 2025-3-25 09:19 作者: 哀悼 時(shí)間: 2025-3-25 14:09
https://doi.org/10.1007/978-3-7091-5323-9luding the choice between neoadjuvant treatment followed by surgery or surgery alone, restorative procedures or APE. If an APE is necessary, this must also be tailored to the individual patient based on patient’s characteristics and the extent of local tumour growth.作者: 輕推 時(shí)間: 2025-3-25 17:08 作者: Oscillate 時(shí)間: 2025-3-25 22:08 作者: 六個(gè)才偏離 時(shí)間: 2025-3-26 01:27
Fliehkraft der Riemen und Seile,, recurrence rate is up to 30%. All other cases, regardless of size, such as non-granular type lesions or mixed type lesions should be treated with endoscopic submucosal dissection. The definitive histopathology of the resected specimen allows further decision (e.g., surgery if invasion depth of tumor is >1000μm).作者: Diastole 時(shí)間: 2025-3-26 05:24 作者: Collar 時(shí)間: 2025-3-26 09:41 作者: Apraxia 時(shí)間: 2025-3-26 15:15
0080-0015 agnosis and multidisciplinary treatment.Written by some of tThis Recent Results in Cancer Research volume provides an up-to-date overview of the multidisciplinary management of locally confined rectal cancer as well as colorectal cancer with synchronous resectable liver metastases. The contents comp作者: 肌肉 時(shí)間: 2025-3-26 20:37
Book 2014pters offer a comprehensive view on the latest recommendations in diagnosis and multidisciplinary treatment. Every clinician involved in the care of patients with rectal cancer will find this book interesting and helpful.作者: 沒(méi)花的是打擾 時(shí)間: 2025-3-27 00:57
https://doi.org/10.1007/978-90-313-9647-4f early stage tumours is likely to increase following greater implementation in screening programs. The goal of this invited review is to provide recommendations based on the consensus discussion on the information from preoperative imaging that is of relevance for clinical decision-making for patients with early rectal cancer.作者: expound 時(shí)間: 2025-3-27 03:45 作者: 名義上 時(shí)間: 2025-3-27 07:55
Book 2014 well as colorectal cancer with synchronous resectable liver metastases. The contents comprise the majority of the invited contributions from the Second St. Gallen EORTC Gastrointestinal Cancer Conference, held on 6-8 March 2014 in St. Gallen, Switzerland. Written by some of the world’s leading expe作者: misanthrope 時(shí)間: 2025-3-27 12:38 作者: octogenarian 時(shí)間: 2025-3-27 17:27 作者: 移動(dòng) 時(shí)間: 2025-3-27 18:23 作者: 黃油沒(méi)有 時(shí)間: 2025-3-27 22:03 作者: Axon895 時(shí)間: 2025-3-28 03:57
https://doi.org/10.1007/978-3-662-24753-2erative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17?%. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower作者: otic-capsule 時(shí)間: 2025-3-28 07:30
https://doi.org/10.1007/978-3-7091-5380-2lled surgery in terms of total mesorectal excision (TME) in the trial setting can be associated with much lower local recurrence rates of less than 10?% whether patients receive radiotherapy or not. Because of the high risk of metastatic disease in selected patients, integrating more active chemothe作者: Soliloquy 時(shí)間: 2025-3-28 12:04
,Arbeitsplan und Bauart der Versuchsk?rper,oadjuvant therapy (50?%). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin作者: 懶惰人民 時(shí)間: 2025-3-28 18:19
https://doi.org/10.1007/978-3-662-33071-5 was probably more efficient (in terms of ypCR) than short course (25/5), and (4) capecitabine was as efficient as 5 FU but oxaliplatin was not adding benefit. Overall, the gains of nCRT remain modest and it is mainly a reduction in local relapse not exceeding 5?%, but no benefit in survival and nei作者: 工作 時(shí)間: 2025-3-28 20:55
https://doi.org/10.1007/978-3-662-32623-7e response (pCR) rate was about 10?% higher in the delayed-surgery group. There were no differences in sphincter preservation and R0 resection rate between the two groups. Small studies suggest no differences in the oncological outcomes. Regarding elderly patients who were unfit for chemotherapy, sh作者: anticipate 時(shí)間: 2025-3-29 00:23
https://doi.org/10.1007/978-3-662-33291-7h treatment regimens. While there is hardly an increase in early toxicity after preoperative SCRT with immediate surgery, late toxicity is substantial compared to surgery alone. Early toxicity is more frequent when a longer interval between SCRT and surgery is used and is comparable to the toxicity 作者: 重畫只能放棄 時(shí)間: 2025-3-29 06:30 作者: 敲竹杠 時(shí)間: 2025-3-29 07:58
Total Mesorectal Excision: Open, Laparoscopic or Roboticerative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17?%. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower作者: 易碎 時(shí)間: 2025-3-29 12:29 作者: magnate 時(shí)間: 2025-3-29 17:22
Quality of Life After Surgery for Rectal Canceroadjuvant therapy (50?%). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin作者: Fibroid 時(shí)間: 2025-3-29 21:08 作者: uveitis 時(shí)間: 2025-3-30 03:26 作者: bromide 時(shí)間: 2025-3-30 05:36 作者: overshadow 時(shí)間: 2025-3-30 08:33
0080-0015 plinary treatment. Every clinician involved in the care of patients with rectal cancer will find this book interesting and helpful.978-3-319-37866-4978-3-319-08060-4Series ISSN 0080-0015 Series E-ISSN 2197-6767
